KATHERINE LINDER
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology HACKENSACK, NJ NPI 1417358367
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology NJ TAIHO ONCOLOGY, INC. All categories
General Payments — all program years on this page
$1,070.40
- Category: General Payments
- Program years: PY2021–2024
- Record count: 64
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $592.89 across 34 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $592.89 | 34 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| TAIHO ONCOLOGY, INC. | $114.74 | 6 |
| Blueprint Medicines Corporation | $100.37 | 6 |
| Incyte Corporation | $54.20 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.11 | 3 |
| SOBI, INC | $34.61 | 2 |
| Celgene Corporation | $32.12 | 2 |
| PharmaEssentia USA Corporation | $31.88 | 2 |
| Daiichi Sankyo Inc. | $28.31 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.05 | 1 |
| Rigel Pharmaceuticals, Inc. | $21.97 | 1 |
| GlaxoSmithKline, LLC. | $20.49 | 1 |
| Astellas Pharma US Inc | $18.61 | 1 |
| Geron Corporation | $16.76 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.20 | 1 |
| BARD PERIPHERAL VASCULAR, INC. | $14.90 | 1 |
| Adaptive Biotechnologies Corporation | $14.57 | 1 |
By program year
Records — PY2024 (34)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.